Regulatory aspects of pharmaceuticals exports in Gulf cooperation council countries

S. Pateriya; M. D. Janodia; P. B. Deshpande; V. S. Ligade; K. B. Talole; T. Kulshrestha; Y. Kamariya; P. B. Musmade; N. Udupa

doi:10.4103/0975-1483.80305

Regulatory aspects of pharmaceuticals exports in Gulf cooperation council countries

S. Pateriya, M. D. Janodia, P. B. Deshpande, V. S. Ligade, K. B. Talole, T. Kulshrestha, Y. Kamariya, P. B. Musmade^*, N. Udupa

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

The Gulf cooperation council (GCC) region is considered as "Emerging market" for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

Original language	English
Pages (from-to)	155-162
Number of pages	8
Journal	Journal of Young Pharmacists
Volume	3
Issue number	2
DOIs	https://doi.org/10.4103/0975-1483.80305
Publication status	Published - 2011

All Science Journal Classification (ASJC) codes

Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.4103/0975-1483.80305

Cite this

@article{1bea4de01f06443780dfbe561be50287,

title = "Regulatory aspects of pharmaceuticals exports in Gulf cooperation council countries",

abstract = "The Gulf cooperation council (GCC) region is considered as {"}Emerging market{"} for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.",

author = "S. Pateriya and Janodia, \{M. D.\} and Deshpande, \{P. B.\} and Ligade, \{V. S.\} and Talole, \{K. B.\} and T. Kulshrestha and Y. Kamariya and Musmade, \{P. B.\} and N. Udupa",

year = "2011",

doi = "10.4103/0975-1483.80305",

language = "English",

volume = "3",

pages = "155--162",

journal = "Journal of Young Pharmacists",

issn = "0975-1483",

publisher = "EManuscript Technologies",

number = "2",

}

TY - JOUR

T1 - Regulatory aspects of pharmaceuticals exports in Gulf cooperation council countries

AU - Pateriya, S.

AU - Janodia, M. D.

AU - Deshpande, P. B.

AU - Ligade, V. S.

AU - Talole, K. B.

AU - Kulshrestha, T.

AU - Kamariya, Y.

AU - Musmade, P. B.

AU - Udupa, N.

PY - 2011

Y1 - 2011

N2 - The Gulf cooperation council (GCC) region is considered as "Emerging market" for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

AB - The Gulf cooperation council (GCC) region is considered as "Emerging market" for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

UR - https://www.scopus.com/pages/publications/80052208949

UR - https://www.scopus.com/inward/citedby.url?scp=80052208949&partnerID=8YFLogxK

U2 - 10.4103/0975-1483.80305

DO - 10.4103/0975-1483.80305

M3 - Article

AN - SCOPUS:80052208949

SN - 0975-1483

VL - 3

SP - 155

EP - 162

JO - Journal of Young Pharmacists

JF - Journal of Young Pharmacists

IS - 2

ER -

Regulatory aspects of pharmaceuticals exports in Gulf cooperation council countries

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this